Pfizer is about to strike a deal with the U.S. government to supply at least tens of millions more doses of its COVID-19 vaccine candidate next year in exchange for a government directive that gives it better access to manufacturing supplies, the New York Times reported. . Tuesday.
An agreement could be announced as early as Wednesday, the paper reported, citing people familiar with the discussions.
Pfizer did not immediately respond to a request from Reuters for comment.
Pfizer and partner BioNTech SE and rival Moderna Inc recently won US emergency approval for their respective vaccine candidates.
The US government has signed a deal with Pfizer for 100 million doses of its vaccine, which will be rolled out across the country.
According to the NYT report, the government will request 100 million additional doses from Pfizer from April to June.
In return, the deal calls on the government to call on the Defense Production Act to give Pfizer better access to about nine specialty products it needs to make the vaccine, the report said.
© 2020 Thomson / Reuters. All rights reserved.